Logo image of OPA

MAGNUM OPUS ACQUISITION LT-A (OPA) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:OPA - KYG5S70A1049 - Common Stock

10.795 USD
+0.01 (+0.05%)
Last: 1/23/2024, 7:53:27 PM
Fundamental Rating

1

OPA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of OPA have multiple concerns. OPA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OPA had positive earnings in the past year.
OPA had a negative operating cash flow in the past year.
OPA Yearly Net Income VS EBIT VS OCF VS FCFOPA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 5M -5M 10M 15M

1.2 Ratios

Industry RankSector Rank
ROA 22.76%
ROE 28.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OPA Yearly ROA, ROE, ROICOPA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2 -2 4 6

1.3 Margins

OPA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OPA Yearly Profit, Operating, Gross MarginsOPA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for OPA remains at a similar level compared to 1 year ago.
The debt/assets ratio for OPA is higher compared to a year ago.
OPA Yearly Shares OutstandingOPA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M
OPA Yearly Total Debt VS Total AssetsOPA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

OPA has an Altman-Z score of 4.34. This indicates that OPA is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that OPA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 4.34
ROIC/WACCN/A
WACCN/A
OPA Yearly LT Debt VS Equity VS FCFOPA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.07 indicates that OPA may have some problems paying its short term obligations.
OPA has a Quick Ratio of 0.07. This is a bad value and indicates that OPA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
OPA Yearly Current Assets VS Current LiabilitesOPA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

OPA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 287.50%, which is quite impressive.
EPS 1Y (TTM)287.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y26.47%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OPA Yearly Revenue VS EstimatesOPA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 50M 100M 150M 200M 250M
OPA Yearly EPS VS EstimatesOPA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 0.1 0.2 0.3 0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

OPA is valuated rather expensively with a Price/Earnings ratio of 17.41.
OPA is valuated rather cheaply when we compare the Price/Earnings ratio to 26.38, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 24.86, OPA is valued on the expensive side.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, OPA is valued at the same level.
Industry RankSector Rank
PE 17.41
Fwd PE 24.86
OPA Price Earnings VS Forward Price EarningsOPA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPA Per share dataOPA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

OPA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OPA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGNUM OPUS ACQUISITION LT-A

NYSE:OPA (1/23/2024, 7:53:27 PM)

10.795

+0.01 (+0.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-14 2023-11-14
Earnings (Next)04-02 2024-04-02
Inst Owners0.47%
Inst Owner Change-64.07%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap119.72M
Revenue(TTM)N/A
Net Income(TTM)15.52M
Analysts80
Price Target15.3 (41.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.41
Fwd PE 24.86
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB 2.23
EV/EBITDA N/A
EPS(TTM)0.62
EY5.74%
EPS(NY)0.43
Fwd EY4.02%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS4.85
TBVpS4.85
PEG (NY)0.66
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 22.76%
ROE 28.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 4.34
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)287.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y26.47%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-49.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.53%
OCF growth 3YN/A
OCF growth 5YN/A

MAGNUM OPUS ACQUISITION LT-A / OPA FAQ

Can you provide the ChartMill fundamental rating for MAGNUM OPUS ACQUISITION LT-A?

ChartMill assigns a fundamental rating of 1 / 10 to OPA.


Can you provide the valuation status for MAGNUM OPUS ACQUISITION LT-A?

ChartMill assigns a valuation rating of 2 / 10 to MAGNUM OPUS ACQUISITION LT-A (OPA). This can be considered as Overvalued.


How profitable is MAGNUM OPUS ACQUISITION LT-A (OPA) stock?

MAGNUM OPUS ACQUISITION LT-A (OPA) has a profitability rating of 0 / 10.


What is the valuation of MAGNUM OPUS ACQUISITION LT-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MAGNUM OPUS ACQUISITION LT-A (OPA) is 17.41 and the Price/Book (PB) ratio is 2.23.


What is the earnings growth outlook for MAGNUM OPUS ACQUISITION LT-A?

The Earnings per Share (EPS) of MAGNUM OPUS ACQUISITION LT-A (OPA) is expected to grow by 26.47% in the next year.